Olangkaya, Sittie .

HRN: 28-71-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CEFTRIAXONE 1G (VIAL)
03/18/2026
03/25/2026
IV
2G
OD
INFECTED RASHES
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines